Prothena | PRTA - Trade Debtors


Prothena reported $5.16M in Trade Debtors for its fiscal quarter ending in December of 2023.





Trade Debtors Change Date
Acadia Pharmaceuticals USD 148.23M 8.79M Dec/2025
Agios Pharmaceuticals USD 16.13M 5.56M Mar/2026
Akebia Therapeutics USD 47.03M 19.19M Dec/2025
ALKERMES USD 334.02M 21.08M Dec/2025
Alnylam Pharmaceuticals USD 883.96M 106.39M Mar/2026
Amgen USD 9.14B 432M Mar/2026
Biogen USD 1.79B 76.6M Mar/2026
BioMarin Pharmaceutical USD 903.91M 4.3M Mar/2026
Exelixis USD 286.92M 24.38M Dec/2025
Immunic USD 333K 156K Dec/2025
Incyte USD 1.05B 27.09M Mar/2026
Ionis Pharmaceuticals USD 74M 8M Mar/2026
MacroGenics USD 13.37M 55.86M Dec/2025
Nektar Therapeutics USD 1.78M 1.12M Dec/2025
Neurocrine Biosciences USD 686.8M 41.2M Dec/2025
Prothena USD 5.16M 0 Dec/2023
Regeneron Pharmaceuticals USD 5.73B 10.1M Mar/2026
Ultragenyx Pharmaceutical USD 158M 45.46M Dec/2025
Vertex Pharmaceuticals USD 2B 56.7M Mar/2026
Xoma USD 14.78M 4.96M Jun/2024